- Justice Department charges 15 for $90M+ in alleged healthcare fraud, expands strike force
- UnitedHealth’s PBM names CFO
- Tennessee becomes 2nd state to ban PBMs from owning pharmacies
- Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show
- 40% lower physician distress, 245% more violence reporting: Workforce retention strategies gaining traction
- 15 new behavioral health study findings to know
- APRN charged in $1.35M Medicare fraud scheme
- Florida woman faces charges of practicing unlicensed dentistry
- GI of the Rockies launches AI-powered care program
- Deputy injured in Indiana hospital shooting
- Legacy Health-backed insurer PacificSource to exit ACA market, pull out of Montana entirely
- Expanded federal scrutiny reshapes how hospitals govern risk, compliance
- The instability compounding the anesthesiologist shortage
- ADA proposes standards on dental cartridges, water quality
- The unraveling of prior authorization: 5 things to know
- The hospital bad debt and charity care crisis: 20 things to know
- As AI identifies more at-risk patients, health systems face a capacity challenge
- 5 GI power players
- 4 dental insurance updates to know
- Federal appeals court overturns EPA fluoride ruling: 5 notes
- What payers don’t understand about ASC spine surgery
- 3 men sentenced for $6.9M orthotic DME fraud scheme
- What will outpatient cardiology look like in 10 years?
- 15 leadership moves across 4 specialties
- Dental Medicaid disenrollment could cause $86M in added costs
- Park Dental opens Minnesota practice
- AI is about to break healthcare’s scarcity model — if we let it
- The most underrated threat in digital health
- Tennessee orthodontic practice opens 2 locations
- Justice Department charges autism care providers in $46.6M fraud case
- 14.2% of Medicaid patients received mental health ED follow-up: 4 notes
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Leaders sound off on overrated ASC trends
- Dental hygienist employment reaches 222,000: State-by-state breakdown
- Vitana Pediatric & Orthodontic Partners adds 1st Maryland practice
- 10 highest-paying states for dental hygienists in 2026
- US overdose deaths decline for 3rd straight year: What it means for healthcare
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- ACAP warns final ACA rule adds further uncertainty to a market in flux
- AbbVie plots 85 summer layoffs tied to Allergan unit in California
- Quorum Health transitioning to nonprofit for financial pickup
- Women's Health Capitol Hill Day: Advocates lobby to advance budget priorities
- Europe's CHMP gives thumbs up to AZ's breast cancer drug after thumbs down from FDA adcomm
- Novartis, AbbVie plan summer layoffs on opposite coasts
- AstraZeneca, Daiichi beat Gilead to first-line TNBC with FDA nod for Datroway
- Severe Asthma Often Comes With Other Serious Health Problems
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Industry Voices—From claims to compassion: Reclaiming patient advocacy in revenue cycle
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- AbbVie, GSK race up patient reputation leaderboard in the UK
- 3 Medical Routines That Older People May Not Need
- Trump’s $50B Rural Health Bet Meets a Healthcare Desert in North Carolina
- Fierce Pharma Asia—Merck-Kelun ADC’s triple wins; Tools in China licensing deals; Takeda’s $885M antitrust loss
- Tyra creates awareness day with patient advocates to shine light on a rare cancer
- Machine learning-guided lifestyle plans reduce depression symptoms: 3 study notes
- Innovaccer picks up CaduceusHealth to offer end-to-end revenue cycle management
- Acadia psychiatric hospital faces abuse lawsuits
- Massachusetts behavioral health clinics to pay $1.4M to settle fraud allegations
- From 50 days to 7: How 1 system cut behavioral health intake wait times
- Hospitals allege contracted CVS Health subsidiaries pocketed their 340B savings
- Northwell hospital launches in-home behavioral health services
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Ksana Health awarded $17.9M to build behavioral health foundation model
- Lilly accuses church-linked pharmacies, wholesalers and more of running $200M+ rebate fraud scheme
- Study: Brokers increasingly recommending ICHRA to employers
- ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer
- Common Food Preservatives Linked to Major Heart Problems
- Health Tech Weekly Rundown: Prime Healthcare expands virtual sitting tech; CVS Health studies seniors' digital health needs
- Amgen's Tavneos, facing liver injury scrutiny, gets label update in Japan as patient starts resume
- Gilead pledges 400K AmBisome doses to fight visceral leishmaniasis in expanded WHO collab
- With Voxzogo under pressure, BioMarin touts trial win in label expansion bid
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Religious Anti-Abortion Center Finds Opportunity In Town Without OB-GYNs
- CPAP Insurance Rules Too Stringent, Deny Device Coverage To Sleep Apnea Patients Who Would Benefit
- ICE Arrests Are Separating Families. Here’s How To Plan Ahead.
- Colorado Charts Its Own Course on Vaccines Amid Federal Pullback
- OpenEvidence launches hands-free voice AI feature, expands hospital footprint with Cedars-Sinai tie-up
- Inside agency view: Ogilvy Health on AI’s ‘light speed,’ nano influencers and the rise of Ria
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Kennedy dismisses leaders of US Preventive Services Task Force
- Statement on Novel Exchange-Traded Funds (ETFs)
- CMS proposes rule aimed at limiting Medicaid state-directed payments
- WTW: Employers aiming to bulk up AI use for health and benefits
- Freestanding EDs, urgent care acquisition opportunities abound for HCA Healthcare
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Rollback of PFAS Drinking Water Standards Raises Safety Fears
- 'Missed risk': Women's Heart Health Summit explores gaps in research, treatment
- House and Senate Democrats move to overturn CMS’ WISeR AI prior auth pilot
- Designing an agentic, future‑ready tech roadmap for emerging pharma
- Judi Health taps Clear for its identity verification tech
- Canvas Medical unveils Canvas Studio, a customizable EMR workflow tool for clinicians
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Your Handwriting Could Be a Window Into Your Aging Brain
- Democratic senators share plans for Medicare home care benefit, long-term care reform
- GHO Capital, CBC Group plan to merge, forming $21B healthcare investment firm
- Ipsen details growing pains as teens transition to adult care
- Lilly, AbbVie, J&J, AZ lead an uptick in Big Pharma Q1 growth, with Novo again bringing up the rear
- MetroHealth partners with Artisight on smart hospital platform rollout
- How Do Caffeine, Alcohol, Weed, Nicotine Affect MS Symptoms?
- Once-A-Day Pill Effective In Treating Sleep Apnea Without CPAP, Clinical Trial Says
- Teens Turning To Creatine, Not Steroids, For 'Looksmaxxing'
- BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
- Gilead inks another deal with Korean API manufacturer Yuhan, this time worth $140M
- Childhood Trauma Tied to Higher Obesity Risk, But One Caring Adult Can Make A Difference
- Eroding ACA Enrollment Portends Higher Insurance Rates
- Amgen, bidding adieu to CFO, lures Galderma exec with hefty $12.4M bonus
- Watch: The Tug-of-War Over Taxpayer Dollars
- Religious Anti-Abortion Center Finds Opportunity in Town Without OB-GYNs
- CG Life appoints Collette Douaihy as chief creative officer as C-suite buildout continues
- Tarsus taps John Cena for its latest Demodex blepharitis campaign
- Statement on Proposing Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- American Aid Worker Tests Positive for Ebola After DRC Exposure
- Listen to the Latest ‘KFF Health News Minute’
- Headache Medicine: Statement on Proposing Releases for Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- More Kids Seeking Anxiety Help at Routine Doctor Visits, Study Finds
- Statement on Proposing Releases for Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies, and Registered Offering Reform
- Global MedTech Contract Manufactures Finalize Merger
- Global MedTech Contract Manufactures Finalize Merger
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Boston Scientific announces strategic investment in MiRus LLC
- Boston Scientific announces strategic investment in MiRus LLC
- Weed/Opioid Combo Doesn't Help Knee Arthritis Pain
- Losing A Parent Can Dent An Adult's Earning Power
- Ticks Can Creepy-Crawl Your House For Weeks Before Dying, Study Shows
- Kids Keep Getting Stuck in Hospitals, Even After Being Cleared For Discharge
- Short, Intense Radiation Therapy Safe For Prostate Cancer Patients
- Efforts To Understand the Nation’s Drugged Driving Problem Stall Under Trump
- Eroding ACA Enrollment Portends Higher Insurance Rates
- Somewhere Between Cacophony and Euphony
- Ebola Outbreaks in Africa Trigger Global Health Emergency, U.S. Travel Warnings
- Rapid Weight Loss Beats Slow and Steady in New Clinical Trial
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Smog Linked To Lewy Body Dementia Risk, Major Study Finds
- NYC Mold Removal Program Cut Asthma ER Cases By A Quarter, Study Says
- Pregnancy Safe For Women With Myasthenia Gravis, Study Concludes
Chris Pope of The Manhattan Institute believes that preventing states from creating new, extraneous programs and funding them with Medicaid dollars is the best way to cut Medicaid spending. A good idea, but unlikely to actually cut Medicaid spending. More likely to reduce the explosive growth of Medicaid spending which has occurred in this century. Federal Medicaid expenditures have increased from $ 118 billion in FY2000 to $ 557 billion in FY2024, a 472% increase:
https://www.city-journal.org/article/house-republicans-medicaid-spending-proposals
A Better Way to Cut Medicaid Spending
The House GOP’s current plans won’t significantly reduce the program. Republicans should instead seek to slow states’ expansions of it.
By Chris Pope - May 20, 2025Last week, House Republicans unveiled proposals to reform Medicaid, the fast-growing system of federal funding for states to deliver health care to low-income Americans. Their proposal creates the appearance of generating substantial savings by nudging states to restrict enrollment. But the approach is unlikely to slow the overall growth of Medicaid spending, because it does little to reduce states’ ability and incentive to claim ever more federal funding.
In reality, Republicans, who promised not to threaten care for those enrolled, have been unable to identify substantial savings by cutting funds that states rely on to deliver health care to Medicaid enrollees. They would do better to focus on the politically easier and fiscally more significant task of preventing states from further expanding the program’s commitments.
Liberals responded to the House’s modest proposals with predictable outrage. Matthew Yglesias has called it a “War on the poor,” arguing that “Medicaid cuts contained in the bill will cause 8.6 million people to lose their health insurance.” Massachusetts representative Lori Trahan has deemed it “federal overreach, plain and simple, with devastating consequences for the people we represent.”
Critics’ outrage is surely overdone. From 2003 to 2023, Medicaid’s annual cost to federal taxpayers surged from $161 billion to $616 billion. House Republicans’ proposals would merely slow the program’s further spending growth over the coming decade from 4.6 percent per year to 3.7 percent. Even that reduction in growth is likely to overestimate the savings that would occur.
To offset the cost of extending the 2017 tax cuts, the House GOP has attempted to maximize the Congressional Budget Office’s estimate of savings resulting from its proposed reforms to Medicaid. But CBO estimates don’t account for likely hurdles to implementation, such as states finding ways to evade intended cost controls.
When such hurdles are considered, the savings and coverage loss are both much less than they’re cracked up to be. This is by design—and it reflects the GOP’s tiny majorities in both houses of Congress, combined with political pressure from governors and health-care providers who stand to lose revenues.
Opponents of the bill point to major cuts in coverage, which the CBO suggests would generate reductions in spending. Loren Adler and Matthew Fiedler of the Brookings Institution, for example, argue that “House Republicans are cutting health coverage programs in two basic ways: (1) narrowing eligibility and making it harder to enroll and stay enrolled; and (2) shifting Medicaid costs from the federal government to the states.” But neither of these effects are likely to be that large.
Take the bill’s work requirements. Adler and Fielder concede that work requirements would not greatly narrow eligibility because the “overwhelming majority of affected enrollees are already working or otherwise complying.” But they suggest that the administrative burden of demonstrating compliance may lead many who are eligible to lose benefits.
That seems unlikely. The bill allows part-time “community engagement” activities to satisfy work requirements, and states have proven adept at using token employment arrangements to nullify similar mandates in the past. The bill would not even allow states to implement work requirements for several years.
States currently receive up to $9 in federal funds for every $1 they spend on Medicaid benefits for able-bodied adults—a return on investment that even most conservative states have found hard to resist. An important objective of work requirements appears to be giving the remaining holdouts political cover to claim their own portion of the federal bounty by expanding Medicaid. This would greatly increase, rather than reduce, federal spending and Medicaid enrollment—even if CBO does not account for such considerations.
Republicans argue that it’s absurd for the federal government to provide $9 in funding for every $1 states spend on Medicaid benefits for able-bodied adults, while only providing an average of $1.30 for every $1 spent on benefits for children, the disabled, and pregnant women. President Obama proposed replacing this arrangement with an intermediary rate for all beneficiaries, but Republicans plan simply to reduce the higher rate.
Democrats argue that the proposed reduction of funding for states would lead to major cuts in coverage. But the GOP bill would only trim the $9-to-$1 match to $8-to-$1 for blue states whose Medicaid providers also deliver care to illegal immigrants—leaving an enormously lucrative arrangement largely in place. The reduction is more an attempt to influence states’ policies on immigration than an effort to lessen substantially the burden on federal taxpayers.
The House GOP bill may nonetheless generate some modest genuine savings. It tightens enforcement of means tests and attempts to restrict states’ ability to inflate federal matching funds artificially by imposing state taxes on insurers, hospitals, and other medical providers. But similar restrictions on “provider taxes” have been enacted in the past and tend to proceed like a game of Whac-a-Mole: whenever Congress restricts one scheme to inflate Medicaid costs artificially, states construct another.
The only real way to stop states from driving up Medicaid costs is to limit the total amount of federal Medicaid funding each state may claim. This year’s House GOP proposal, unlike the 2017 version, doesn’t even try to do so. The GOP has previously stumbled in attempting to set precise dollar limits on Medicaid funding for states. (Set them too high, and they will do little to constrain the growth of expenditures; too low, and they will unduly disrupt existing care.)
A better approach would be to prohibit high-spending states from unilaterally expanding their Medicaid programs. States that claim more than $20,000 in federal Medicaid funds per poor resident should no longer be permitted to claim additional matching funds for further expansions of benefit packages or eligibility, or extraordinary increases in payments for services undertaken without express authorization by Congress.
The House GOP’s Medicaid reform proposals have failed to generate substantial genuine savings or improvements to the program. Their Republican Senate counterparts have an opportunity to do better.
Christopher Pope is a senior fellow at the Manhattan Institute. Previously, he was director of policy research at West Health, a nonprofit medical research organization; health-policy fellow at the U.S. House Committee on Energy and Commerce; and research manager at the American Enterprise Institute. Pope’s research focuses on healthcare payment policy, and he has recently published reports on hospital-market regulation, entitlement design, and insurance-market reform. His work has appeared in, among others, the Wall Street Journal, Health Affairs, US News and World Report, and Politico.
Pope holds a B.Sc. in government and economics from the London School of Economics and an M.A. and Ph.D. in political science from Washington University in St. Louis.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















